N-Acetyltransferase 2 (NAT2) and Glutathione S-Transferase μ (GSTM1) in Bladder-cancer Patients in a Highly Industrialized Area

References

• Rehn L. Blasengeschwuelste bei Fuchsinarbeitern. Arch Klin Chir. 1895; 50: 588–600.
   Google Scholar
• Hauptverband der gewerblichen Berufsgenossenschaften (ed). Beruflich verursachte Krebserltrankungen. Eine Darstellung der im Zeitraum 1978-1994 anerkanntenIle. St. Augustin; Haupt-verband der gewerblichen Berufsgenossenschaften, 1996.
   Google Scholar
• Golka K, Schoeps W, Kierfeld G, Bolt HM. Urothelerkrankungen als Berufskrankheit. Versicherungsmeclizin. 1994; 46: 158–61.
   PubMedGoogle Scholar
• Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst. 1981; 66: 1191–308.
   PubMed Web of Science ®Google Scholar
• Myslak ZW, Bolt HM. Beruffiche Exposition gegenueber Azofarb-stoffen und Harnblasenkarzinom-Risiko. Zbl Arbeitsmed. 1988; 38: 310–21.
   Google Scholar
• Steineck G, Plato N, Norell SE, Hogstedt C. Urothelial cancer and some industry-related chemicals: an evaluation of the epidemio-logic literature. Am J Ind Med. 1990; 17: 371–91.
   PubMed Web of Science ®Google Scholar
• Vineis P. Epidemiology of cancer from exposure to arylamines. Environ Health Perspect. 1994;102 (suppl 6):7-10.
   Google Scholar
• Wynder EL, Onderdonk J, Mantei N. An epidemiological investi-gation of cancer of the bladder. Cancer. 1963; 16: 1388–407.
   PubMed Web of Science ®Google Scholar
• Cordier S, Clavel J, Limasset JC, et al. Occupational risks of blad-cle'r cancer in France: a multicentre case-control study. Int J Epi-demiol. 1993; 22: 403–11.
   PubMed Web of Science ®Google Scholar
• Schifflers E, Jamart J, Renard V. Tobacco and occupation as risk factors in bladder cancer: a case-control study in Southern Bel-gium. Int J Cancer. 1987; 39: 287–92
   PubMed Web of Science ®Google Scholar
• Golka K, Bandel T, Urfer W, Bolt HM. Berufliche Risikofaktoren fuer Tumoren der Harnblase und der Prostata. Bremerhaven; Wirtschaftsverlag NW, Verlag fuer Nene Wissenschaften, 1995, Schriftenreihe der Bundesanstalt fuer Arbeitsschutz: Forschung; Fb 714.
   Google Scholar
• Golka K, Reich SE. Risk factors for malignat tumours of the uri-nary bladder and the prostate in the German East Ruhr area. In: Frentzel-Beyme R, Ackermann-Liebrich U, Bertazzi A, et al (eds). Environmental Epidemiology in Europe 1995. Bremen, Ger-many: Bremen Institute for Prevention Research and Social Med-icine (BIPS), 1996: 51-62.
   Google Scholar
• Golka K, Schlaefke S, Dickhut S, Reich SE, Urfer W, Bolt HM. An-wendung statistischer Methoden zur Idendfikation beruflicher Risiken fuer maligne Tumoren der Harnblase und der Prostata. Egelsbach: Verlag Haensel-Hohenhausen, 1996. Deutsche Hoch-schulschriften 1088.
   Google Scholar
• Risch A, Wallace DMA, Bathers 5, Sim E. Slow Nacetylation geno-type is a susceptibility factor in occupational and smoking related bladder cancer. Hum Molec Genet. 1995; 4: 231–6.
   Google Scholar
• Golka K, Prior V, Blaszkewicz M, et al. Occupational history as-pects and genetic N-acetyltransferase (NAT2) polymorphism in urothelial cancer patients in Leverkusen, Germany. Scand J Work Environ Health. 1996; 22: 332–8
   PubMed Web of Science ®Google Scholar
• Seidegard J, Pero RW, Miller DG, Beattie EJ. A glutathione trans-ferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis, 1986; 7: 751–3.
   PubMed Web of Science ®Google Scholar
• Bell DA, Taylor JA, Paulson DF, Robertson CN, IYIohler JL, Lucier GW. Genetic risk and carcinogen exposure; a common inherited defect of the carcinogen-metabolism gene glutathione S-trans-ferase M1 (GSTM1) that increases susceptibility to bladder can-cer. J Nad Cancer Inst. 1993; 85: 1159-64
   Google Scholar
• Hirvonen A, Nylund L, Kodba P, Husgafvel-Pursiainen K, Vainio H. Modulation of urinary mutagenicity by genetically determined carcinogen metabolism in smokers. Carcinogenesis. 1994;15; 813–5
   PubMed Web of Science ®Google Scholar
• Statistisches Bundesamt (ed), Klassifizierung der Berufe. Syste-matisches und alphabetisches Verzeichnis der Berufsbenennuns gen. Stuttgart: Metzler-Poeschel Verlag, 1992.
   Google Scholar
• Grant DM, Tang BK, Kalow W. Polymorphic Nacetylation of a caf-feine metabolite. Clin Pharmacol Ther. 1983; 33: 355–9.
   PubMed Web of Science ®Google Scholar
• Roehrkasten R, Raats P, Kreher RP, Blaszkewicz M. Synthesis of the caffeine metabolites 5-acetylamino-6-formylamino-3-methyluracil (AFMU) and 5-acetylamino-6-arnino-3-methyluracil (AAMU) on a preparative scale. Z Naturforsch Teil B. In press.
   Google Scholar
• Fink K, Adams WS, Pfleiderer W. A new urinary pyrimidine, 5-acetyl-6-amino-3-methyluracil, its isolation, identification and syn-thesis. J Biol Chem. 1964; 239: 4250–6.
   PubMed Web of Science ®Google Scholar
• Cascorbi I, Drakoulis N, Broclunoeller J, Maurer A, Sperling K, Roots I. Arylamine Nacetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correla-tion with phenotypic activity. Am J Hum Genet 1995; 57: 581–92
   PubMed Web of Science ®Google Scholar
• Vatsis KP, Weber WW, Bell DA, et al. Nomenclature for N-acetyl-transferases. Pharmocogenetics. 1995; 5: 1–17.
   PubMedGoogle Scholar
• Brochnoeller J, Cascorbi I, Kerb R, Roots I. Combined analysis of inherited polymorphisms in arylamine Nacetyltransferase 2, glu-tathione S-transferases M1 and Ti, microsomal epoxide hydro-lase, and cytochrome P450 enzymes as modulators of bladder can-cer risk. Cancer Res. 1996; 56: 3915-25.
   Google Scholar
• Lower GM Jr, Nilsson T, Nelson CE, Wolf H, Gamsky TE, Bryan GT. NAcetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology: preliminary results in Swe-den and Denmark. Environ Health Perspect. 1979; 29: 79–9.
   Google Scholar
• Lower GM Jr, Bryan GT. Etiology and carcinogenesis: natural sys-tem approaches to causality and control. In: Javadpour N ( ed). Principles and Management of TJrologic Cancer. Baltimore, MD: Williams and Wilkins, 1979: 29-53.
   Google Scholar
• Wolf H, Lower GM Jr, Bryan GT. Role of Nacetyltransferase phe-notype in human susceptibility to bladder carcinogenic aryla-mines. Scand J Urol Nephrol. 1980; 14: 161–5.
   PubMed Web of Science ®Google Scholar
• Cartwright R, Ahmad RA, Barham-Hall D, et al. Role of Nacetyl-transferase phenotypes in bladder carcinogenesis: a pharmaco-genetic epidemiological approach to bladder cancer. Lancet. 1982; 2: 842–5.
   PubMed Web of Science ®Google Scholar
• Woodhouse KW, Adams PC, Clothier A, Mucklow JC, Rawlins MC. NAcetylation phenotype in bladder cancer. Hum Toxicol. 1982; 1: 443–5.
   PubMedGoogle Scholar
• Evans DAP, Eze LC, Whibley EJ. The association of the slow acety-lator phenotype with bladder cancer. J Med Genet. 1983; 20: 330–3.
   PubMed Web of Science ®Google Scholar
• Miller ME, Cosgriff JM. Acetylator phenotype in human bladder cancer. J Urol. 1983; 130: 65–6.
   PubMed Web of Science ®Google Scholar
• Mommsen S, Barfod NM, Aagard J. N-Acetyltransferase pheno-types in the urinary bladder carcinogenesis of a low-risk popula-tion. Carcinogenesis. 1985; 6: 199–201.
   PubMed Web of Science ®Google Scholar
• Hanssen HP, Agarwal DP, Goedde HW, et al. Association of the N-acetylation polymorphism and environmental factors with bladder carcinogenesis. Eur Urol.,1985; 11: 263–6.
   Google Scholar
• Ladero JM, Kwok CK, Jara C, et al. Hepatic acetylator phenotype in bladder cancer patients. Ann Clin Res. 1985; 17: 96–9.
   PubMedGoogle Scholar
• Hanke J, Krajewska B. Acetylation phenotypes and bladder can-cer. J Occup Med. 1990; 32: 917–8.
   PubMedGoogle Scholar
• Roots I, Drakoulis N, Brockmoelleri Polymorphic enzymes and cancer risk: concepts, methodology and data review. In: Kalow W ( ed). Pharmacogenetics of Drug Metabolism. New York: Perga-mon Press, 1992: 815-41.
   Google Scholar
• Kempkes M, Golka K, Reich S, Reckwitz T, Bolt HM. Glutathione S-transferase GSTMI and GSTT1 null genotypes as potential risk factors for urothelial cancer of the bladder. Arch Toxicol. 1996; 71: 123–6.
   PubMed Web of Science ®Google Scholar
• Broclunoeller J, Kerb R, Drakoulis N, Staffeldt B, Roots I. Glu-tathione S-transferase MI and its variants A and B as host factors of bladder cancer susceptibility: a case-control study. Cancer Res. 1994; 54: 4103–11.
   PubMed Web of Science ®Google Scholar
• Grant DM, Tang BK, Kalow W. A simple test for acetylator phe-notype using caffeine. Br J Pharmacol. 1984; 17: 459–64.
   Web of Science ®Google Scholar
• Butler MA, Lang NP, Young JF, et at. Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caf-feine urinary metabolites. Pharmacogenetics. 1992; 2: 116–27.
   Google Scholar
• Braz Vieira da Silva Pontes Z, Vincent-Viry M, Gueg-uen R, Galteau MM, Siest G. Acetylation phenotypes and biological variation in a French Caucasian population. Eur J Clin Chem Clin Biochem. 1993; 31: 59–68.
   Google Scholar
• Lewalter J, Miksche L. Empfehlungen zutr arbMtsrnedizinischen Praevention expositions- umd dispositionsbedingter Arbeitsstoff-13eanspruchungen. Verh Dt Ges Arbeitsmed 1991; 31: 135–9.
   Google Scholar
• Meal PF, Cocker J, Wilson PIK, Gilmour JM. Search for benzidine and its metabolites in urine of workers weighing benzidine-derived dyes. Br J Ind Med. 1981; 38: 191–3.
   PubMedGoogle Scholar
• Dewan A, Jani JP, Patel JS, Gandhi DH, Vatiya MR. Benzidine and its acetylated metabolites in the urine of workers exposed to di-rect black 38. Arch Environ Health. 1988; 43: 269–72.
   PubMed Web of Science ®Google Scholar
• Doll R, Vessey MP, Beasley WR, et al. Mortality of gasworkers--fi-nal report of a prospective study. Br J Ind Med. 1972; 29: 394–406
   PubMedGoogle Scholar
• Manz A, Berger J, Waltsgott H. Zur Frage des Berufskrebses bei Beschaeftigten der Gasindustrie. Bremerhaven: Wirtschaftsverlag NW, Verlag flier Nene Wissenschaften, 1983. Schriftenreihe der Bundesanstalt flier Arbeitsschutz: Forschung; Fb 352.
   Google Scholar
• Hammond EC, Selikoff IJ, Lawther PL, Seidman H. Inhalation of benzpyrene and cancer in man. Ann NY Acad Sci. 1976; 271: 116–24.
   PubMed Web of Science ®Google Scholar